A short description of the method used to perform the test
Headspace Gas Chromatography/Flame Ionization Detection (GC-FID)
NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Lists a shorter or abbreviated version of the Published Name for a test
Lists additional common names for a test, as an aid in searching
Describes the specimen type validated for testing
WB Sodium Heparin
Defines the optimal specimen required to perform the test and the preferred volume to complete testing
Draw blood in a green-top (sodium heparin) tube(s) and send 20 mL in two tubes of sodium heparin whole blood refrigerated. Blood should be drawn at end of shift. Tubes should be filled to prevent loss of volatile compound into headspace.
Specimen Minimum Volume
Defines the amount of sample necessary to provide a clinically relevant result as determined by the Testing Laboratory
Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected
| Hemolysis || NA |
| Lipemia || NA |
| Icterus || NA |
| Other || NA |
Specimen Stability Information
Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included
WB Sodium Heparin
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Normal (unexposed population):
Blood benzene concentrations of greater than 0.1 mg/L correlate with exposure to greater than 10 ppm benzene in air.
Blood benzene concentrations greater than 0.90 mg/L have been observed in fatal cases of benzene exposure.
Indicates whether the report includes an additional document with charts, images or other enriched information
Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.
The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.
7 to 11 days
Specimen Retention Time
Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded
Performing Laboratory Location
Indicates the location of the laboratory that performs the test
Medtox Laboratories, Inc.
Test Setup Resources
Test setup information contains test file definition details to support order and result interfacing between Mayo Clinic Laboratories and your Laboratory Information System.
SI Sample Reports
International System (SI) of Unit reports are provided for a limited number of tests. These reports are intended for international account use and are only available through MayoLINK accounts that have been defined to receive them.
SI Normal Reports |
SI Abnormal Reports